|
Title
|
|
|
|
The TEMPI syndrome
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| The TEMPI syndrome is a rare and acquired disorder characterized by 5 salient features, which compose its name: (1) telangiectasias; (2) elevated erythropoietin and erythrocytosis; (3) monoclonal gammopathy; (4) perinephric fluid collections; and (5) intrapulmonary shunting. Complete resolution of symptoms following treatment with plasma celldirected therapy supports the hypothesis that the monoclonal antibody is causal and pathogenic. Understanding the basis of the TEMPI syndrome will depend on the identification of additional patients and a coordinated international effort. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Blood / American Society of Hematology. - New York, N.Y.
|
|
|
Publication
|
|
|
|
New York, N.Y.
:
2020
|
|
|
ISSN
|
|
|
|
0006-4971
|
|
|
DOI
|
|
|
|
10.1182/BLOOD.2019004216
|
|
|
Volume/pages
|
|
|
|
135
:15
(2020)
, p. 1199-1203
|
|
|
ISI
|
|
|
|
000525866300006
|
|
|
Pubmed ID
|
|
|
|
32108223
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|